MKI67 and ductal breast carcinoma in situ: The relatively higher OS observed in our study may be attributed to several factors, including ductal carcinoma in situ (9.1%), increased rates of adjuvant RTx, lower histologic grade, and lower Ki-67 expression compared with those of other studies [7,20].